Life Sciences

The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.

The company will use the funds to expand partnerships with mental health nonprofits and government agencies.

The company will use the funds to grow its team, accelerate product development and test strategies to scale its business.

The solicitation seeks projects that leverage technology and the microgravity environment in space to create therapies to treat significant diseases on Earth.

Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharma's perspective on digital health investments and partnerships for sector growth.

Create Health Ventures will focus on funding early-stage digital health companies led by founders with healthcare backgrounds.

ReviR Therapeutics secures $30 million for its drug discovery platform. RetiSpec raises $10 million for its eye-diagnostics offering. SoundHealth scores $7 million for its acoustics medical device for nasal congestion.

Scopio Labs secured $42 million in Series D funding, and robotics company NAVIGANTIS closed a $12 million Series A round.

The platform includes language support, call-to-text functionality, a high degree of automation and community outreach features.

Duke-NUS Medical School's LIVE Ventures will bring together scientists and public and private sector entities to commercialize academic research concepts.